Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
Transplantation. 2005 Feb 15;79(3):261-8.

Liver transplantation and hepatitis C virus: systematic review of antiviral therapy.

Author information

  • 1Liver Transplantation and Hepatobiliary Medicine Royal Free Hospital, Pond Street, London NW3 2QG, United Kingdom.


Antiviral therapy for recurrent hepatitis C after liver transplantation is increasingly used. This systematic review presents both viral and histological response in three areas: pretransplant (5 studies/180 patients), preemptive therapy soon after transplant (10 studies/417 patients), and therapy for established disease (75 studies/2027 patients). There were only 16 randomized studies (543 patients). Significant dose reductions and drug stoppage rates occurred. The data on histological improvement and risk of rejection are conflicting. Even the best antiviral therapy (pegylated interferon/ribavirin) is neither easily used nor reasonably effective. The best strategy will be pretransplant treatment, most likely with newer agents.

Comment in

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk